Extendicare Inc. (TSE:EXE - Get Free Report)'s stock price passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of C$10.12 and traded as high as C$13.35. Extendicare shares last traded at C$13.06, with a volume of 305,519 shares changing hands.
Wall Street Analyst Weigh In
EXE has been the topic of a number of recent research reports. Cormark upgraded shares of Extendicare to a "moderate buy" rating in a research note on Wednesday, February 19th. TD Securities lifted their price target on Extendicare from C$10.50 to C$13.00 and gave the company a "hold" rating in a report on Monday, March 3rd. Royal Bank of Canada boosted their price target on Extendicare from C$9.50 to C$11.00 and gave the stock a "sector perform" rating in a research report on Thursday, November 28th. Finally, BMO Capital Markets raised their price objective on Extendicare from C$11.00 to C$13.50 in a research report on Monday, March 3rd.
Check Out Our Latest Analysis on EXE
Extendicare Stock Performance
The company has a quick ratio of 0.98, a current ratio of 0.62 and a debt-to-equity ratio of 283.02. The firm has a market capitalization of C$1.09 billion, a price-to-earnings ratio of 16.66 and a beta of 1.26. The business has a 50-day moving average price of C$11.41 and a 200-day moving average price of C$10.25.
Extendicare Dividend Announcement
The company also recently announced a monthly dividend, which was paid on Monday, March 17th. Investors of record on Monday, March 17th were paid a $0.04 dividend. The ex-dividend date was Friday, February 28th. This represents a $0.48 dividend on an annualized basis and a yield of 3.67%. Extendicare's dividend payout ratio (DPR) is 61.20%.
About Extendicare
(
Get Free Report)
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.
See Also
Before you consider Extendicare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Extendicare wasn't on the list.
While Extendicare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
